VT H0676

Office of Professional Regulation must consider all options to ensure animal-derived thyroid medications, including desiccated thyroid extract, remain available to Vermont patients who respond better to them than synthetic alternatives

Consultation required with the Department of Financial Regulation, health care professionals, health insurers, patients with hypothyroidism and thyroid-related disorders, and other stakeholders

Office of Professional Regulation and Department of Financial Regulation must promptly implement all feasible options that do not require legislative action

Report due to House Committee on Health Care and Senate Committee on Health and Welfare by January 15, 2027, including findings, recommendations, implemented options, and any proposals requiring legislation

Act takes effect upon passage